Search Results - "Hummers, L."
-
1
Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension
Published in The European respiratory journal (01-08-2011)“…The aim of this study was to examine the causes and outcomes of hospitalisation in patients with pulmonary arterial hypertension (PAH). 205 consecutive…”
Get full text
Journal Article -
2
Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension
Published in The European respiratory journal (01-01-2010)“…N-terminal pro-brain natriuretic peptide (NT-proBNP) is a marker of neurohormonal activation that is useful in the diagnosis and prognosis of various forms of…”
Get full text
Journal Article -
3
PM-Scl and Th/To in systemic sclerosis: a comparison of different autoantibody assays
Published in Clinical rheumatology (01-07-2021)“…Objective To compare test characteristics of the Euroimmun line blot assay with other assays for two uncommon autoantibody specificities in systemic…”
Get full text
Journal Article -
4
A case–control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma)
Published in Gut (01-12-2006)“…Background: Atrophy of the smooth muscle layers of the muscularis propria characterises oesophageal involvement in systemic sclerosis (scleroderma). The…”
Get full text
Journal Article -
5
Proposed diagnostic criteria and nosology of acute transverse myelitis
Published in Neurology (27-08-2002)“…Acute transverse myelitis (ATM) is a focal inflammatory disorder of the spinal cord, resulting in motor, sensory, and autonomic dysfunction. A set of uniform…”
Get full text
Journal Article -
6
Biomarkers of vascular disease in scleroderma
Published in Rheumatology (Oxford, England) (01-10-2008)“…Vascular disease is present in every patient with scleroderma and is a major source of morbidity and mortality. There is a subset of patients who will develop…”
Get full text
Journal Article -
7
Recurrent transverse myelitis associates with anti-ro (SSA) autoantibodies
Published in Neurology (13-01-2004)“…Transverse myelitis (TM) is an idiopathic inflammatory disorder of the spinal cord. The authors observed cases of recurrent TM in patients where anti-Ro (SSA)…”
Get full text
Journal Article -
8
High-dose cyclophosphamide without stem cell rescue in scleroderma
Published in Annals of the rheumatic diseases (01-06-2008)“…To investigate the safety and tolerability of high-dose cyclophosphamide without stem cell rescue in scleroderma. An open-label, single-site, uncontrolled…”
Get more information
Journal Article -
9
The "tank top sign": a unique pattern of skin fibrosis seen in pansclerotic morphea
Published in Annals of the rheumatic diseases (01-09-2009)Get more information
Journal Article -
10
Distinct recognition of antibodies to centromere proteins in primary Sjögren’s syndrome compared with limited scleroderma
Published in Annals of the rheumatic diseases (01-08-2006)“…Background: Anticentromere antibodies are characteristically observed in scleroderma but have recently been reported in other autoimmune rheumatic disorders,…”
Get full text
Journal Article -
11
Abnormal exhaled ethane concentrations in scleroderma
Published in Biomarkers (01-01-2006)“…Abstract Scleroderma (systemic sclerosis) is a chronic multisystem autoimmune disease in which oxidative stress is suspected to play a role in the…”
Get full text
Journal Article -
12
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
Published in Annals of the rheumatic diseases (01-10-2010)“…To determine the causes and predictors of mortality in systemic sclerosis (SSc). Patients with SSc (n=5860) fulfilling the American College of Rheumatology…”
Get more information
Journal Article -
13
Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases
Published in Annals of the rheumatic diseases (01-03-2019)“…Immune-mediated inflammatory diseases (IMIDs) are heterogeneous and complex conditions with overlapping clinical symptoms and elevated familial aggregation,…”
Get more information
Journal Article -
14
Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-12-2019)“…Objective To investigate the relationship between Krebs von den Lungen 6 (KL‐6) and CCL18 levels and the severity and progression of systemic sclerosis…”
Get full text
Journal Article -
15
Distinct clinical trajectories of gastrointestinal progression among patients with systemic sclerosis
Published in Rheumatology (Oxford, England) (30-08-2024)“…Systemic sclerosis (SSc) is heterogeneous in its clinical presentation. Common manifestations cluster together, defining unique subgroups. This investigation…”
Get full text
Journal Article -
16
Troponin elevation independently associates with mortality in systemic sclerosis
Published in Clinical and experimental rheumatology (01-10-2022)“…Cardiac involvement is common in systemic sclerosis (SSc), and elevated troponin may be the only sign of ongoing myocardial disease. The objective was to…”
Get more information
Journal Article -
17
-
18
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
Published in Nature genetics (01-05-2010)“…Timothy Radstake and Maureen Mayes and colleagues report results of a genome-wide association study of systemic sclerosis. They identify a new susceptibility…”
Get full text
Journal Article -
19
Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis: DUAL-1 and DUAL-2 Randomized Clinical Trials
Published in JAMA : the journal of the American Medical Association (10-05-2016)“…IMPORTANCE: Digital ulcers in patients with systemic sclerosis are associated with pain and poor quality of life. Endothelin-1 promotes vasculopathy in…”
Get full text
Journal Article -
20
A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale
Published in Clinical and experimental rheumatology (01-07-2021)“…The multi-systemic, heterogenous nature of diffuse cutaneous systemic sclerosis (dcSSc) presents challenges in designing clinical studies that can demonstrate…”
Get more information
Journal Article